Prof.dr. P.L.C.M. van Riel

Pagina-navigatie:

filter results

Type

Article (209)

Date

Accessibility

Institution

1-10 out of 209 results by:date

Save search results

Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care. (2010)

Authors:	Janssens, H.J.E.M.; Janssen, M.; Lisdonk, E.H. van de; Fransen, J.; Riel, P.L.C.M. van; Weel, C. van
In:	Annals of the Rheumatic Diseases, 69, 1255 - 1256. ISSN 0003-4967.

Validity of the disease activity score in undifferentiated arthritis. (2010)

Authors:	Fransen, J.; Visser, K.; Dongen, H. van; Huizinga, T.; Riel, P.L.C.M. van; Heijde, D.M.F.M. van der
In:	ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 62, 1392 - 1398. ISSN 2151-4658.

Abstract:

OBJECTIVE: To study whether the Disease Activity Score (DAS) is a valid measure of disease activity in undifferentiated arthritis (UA). METHODS: Data from a randomized, double-blind, placebo-controlled trial of methotrexate (MTX) and placebo involving 110 patients with UA were used. Data included ba

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. (2010)

Authors:	Furst, D.E.; Keystone, E.C.; Fleischmann, R.; Mease, P.; Breedveld, F.C.; Smolen, J.S.; Kalden, J.R.; Braun, J.; Bresnihan, B.; Burmester, G.R.; Benedetti, F. De; Dorner, T.; Emery, P.; Gibofsky, A.; Kavanaugh, A.; Kirkham, B.; Schiff, M.H.; Sieper, J.; Singer, N.; Riel, P.L.C.M. van; Weinblatt, M.E.; Weisman, M.H.; Winthrop, K.
In:	Annals of the Rheumatic Diseases, 69, i2 - 29. ISSN 0003-4967.

Unregulated prescribing of anti-tumour necrosis factor agents does not mean inappropriate prescribing. (2010)

Authors:	Ng, C.T.; Radovits, B.J.; Kievit, W.; Fransen, J.; Riel, P.L.C.M. van; Fitzgerald, O.; Veale, D.J.; Bresnihan, B.
In:	Annals of the Rheumatic Diseases, 69, 313 - 314. ISSN 0003-4967.

Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis. (2010)

Authors:	Pavy, S.; Toonen, E.J.M.; Miceli-Richard, C.; Barrera, P.; Riel, P.L.C.M. van; Criswell, L.A.; Mariette, X.; Coenen, M.J.H.
In:	Annals of the Rheumatic Diseases, 69, 1022 - 1028. ISSN 0003-4967.

Abstract:

BACKGROUND: There is a need for biomarkers that can predict anti-tumour necrosis factor (anti-TNF) treatment outcome in patients with rheumatoid arthritis (RA). Several studies have suggested that the rare A allele of the tumour necrosis factor alpha (TNFA) -308G-->A polymorphism could be associa

Time to achieve remission determines time to be in remission. (2010)

Authors: Schipper, L.G.; Fransen, J.; Broeder, A. den; Riel, P.L.C.M. van
In: Arthritis Research & Therapy, 12, R97 - R97. ISSN 1478-6362.

Abstract:
INTRODUCTION: Though remission is currently a treatment goal in patients with rheumatoid arthritis (RA), the number of patients who achieve and sustain remission in daily practice is still small. It is suggested that early remission will be associated with sustainability of remission. The aim was to
Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. (2010)

Authors: Schipper, L.G.; Hulst, L.T.C. van; Grol, R.P.T.M.; Riel, P.L.C.M. van; Hulscher, M.E.J.L.; Fransen, J.
In: Rheumatology, 49, 2154 - 2164. ISSN 1462-0324.

Abstract:
OBJECTIVES: Tight control studies including regular assessments of disease activity have shown that this approach has beneficial effects on disease activity, disability and joint damage in treating RA patients. Some of these studies included tight control with protocolized treatment, while others ap
The relationship between change in subjective outcome and change in disease: a potential paradox. (2010)

Authors: Kievit, W.; Hendrikx, J.; Stalmeier, P.F.M.; Laar, M.A. van de; Riel, P.L.C.M. van; Adang, E.M.M.
In: Quality of Life Research, 19, 985 - 994. ISSN 0962-9343.

Abstract:
BACKGROUND: Response shift theory suggests that improvements in health lead patients to change their internal standards and re-assess former health states as worse than initially rated when using retrospective ratings via the then-test. The predictions of response shift theory can be illustrated usi

Authors:	Schipper, L.G.; Fransen, J.; Broeder, A. den; Riel, P.L.C.M. van
In:	Arthritis Research & Therapy, 12, R97 - R97. ISSN 1478-6362.

Authors:	Schipper, L.G.; Hulst, L.T.C. van; Grol, R.P.T.M.; Riel, P.L.C.M. van; Hulscher, M.E.J.L.; Fransen, J.
In:	Rheumatology, 49, 2154 - 2164. ISSN 1462-0324.

Authors:	Kievit, W.; Hendrikx, J.; Stalmeier, P.F.M.; Laar, M.A. van de; Riel, P.L.C.M. van; Adang, E.M.M.
In:	Quality of Life Research, 19, 985 - 994. ISSN 0962-9343.

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. (2010)

Authors:	Gaujoux-Viala, C.; Smolen, J.S.; Landewe, R.; Dougados, M.; Kvien, T.K.; Mola, E.M.; Scholte-Voshaar, M.; Riel, P.L.C.M. van; Gossec, L.
In:	Annals of the Rheumatic Diseases, 69, 1004 - 1009. ISSN 0003-4967.

Abstract:

OBJECTIVES: To assess the efficacy and safety of synthetic disease-modifying antirheumatic drugs (DMARDs) in adults with rheumatoid arthritis (RA)-a first step in a European League Against Rheumatism (EULAR) initiative to produce recommendations for the management of RA. METHODS: A systematic review

Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. (2010)

Authors:	Martin, J.E.; Alizadeh, B.Z.; Gonzalez-Gay, M.A.; Balsa, A.; Pascual-Salcedo, D.; Fernandez-Gutierrez, B.; Raya, E.; Franke, L.; Slot, R. van 't; Coenen, M.J.H.; Riel, P.L.C.M. van; Radstake, T.R.D.J.; Koeleman, B.P.; Martin, J.
In:	Arthritis and Rheumatism, 62, 3183 - 3190. ISSN 0004-3591.

Abstract:

OBJECTIVE: Genome-wide association studies carried out in rheumatoid arthritis (RA) have led to the discovery of several genetic associations with this disease. Still, the current associated genetic variations can explain only part of the genetic risk involved in RA, and it is well recognized that t

Pages:

previous

<< < 1 2 3 4 5 6 7 8 9 10 > >>